about
Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative diseaseCerebellar pathology in Friedreich's ataxia: atrophied dentate nuclei with normal iron content.Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study.Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile ironIron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood.E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.Brain iron accumulation in aging and neurodegenerative disorders.Friedreich's ataxia, frataxin, PIP5K1B: echo of a distant fracas.Oxidative stress in inherited mitochondrial diseases.Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia.Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia.Cysteine desulfurase is regulated by phosphorylation of Nfs1 in yeast mitochondria.Frataxin silencing alters microtubule stability in motor neurons: implications for Friedreich's ataxia.Drosophila melanogaster Models of Friedreich's Ataxia.Synthesis of frataxin genes by direct assembly of serial deoxyoligonucleotide primers and its expression in Escherichia coli
P2860
Q27015737-4311EB34-EC83-4278-BC15-46A87C694AC3Q30426640-1A53F9C8-845A-45CE-A833-6A2EE581B43CQ30946340-2E23703C-0040-4660-8DAE-A8563744C164Q34761250-74EA0592-832E-4B5D-86DC-B65396314A4DQ34940777-1C64FEB4-290F-444E-820B-2E73ABCCA5EFQ36274297-6424F7EE-2498-4937-83CB-FEAAB165D2ECQ36488119-598EE360-8A09-4B93-A908-D4E72BC94639Q37557229-16ABAB47-8DF7-4991-B124-F814B8F4098AQ37670668-62B635AD-150C-495D-8FFB-2B124DB4DB61Q38067144-4FF11591-07DC-46D9-9D01-502A4B766453Q38160224-85BE3291-98E0-4155-8FF3-5862A45DAFAAQ38527423-551B3939-3D8E-44E8-8A3D-50C5239E1318Q42773797-6B67AA58-E738-4CDE-8F2F-751DB07C0182Q47260731-08BE3256-E5EC-413F-81B3-D524746DBCF5Q47755054-FFE7F042-D812-413B-A43F-9E8F62132A79Q51575796-7EA125AB-41D1-4743-BCA8-64293EACCEADQ55073764-84682FB3-9F16-41B5-9951-291918366E3BQ57972012-3F54FB0A-4026-4008-BD3A-65E006C9A755
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Therapeutic developments in Friedreich ataxia
@ast
Therapeutic developments in Friedreich ataxia
@en
Therapeutic developments in Friedreich ataxia
@nl
type
label
Therapeutic developments in Friedreich ataxia
@ast
Therapeutic developments in Friedreich ataxia
@en
Therapeutic developments in Friedreich ataxia
@nl
prefLabel
Therapeutic developments in Friedreich ataxia
@ast
Therapeutic developments in Friedreich ataxia
@en
Therapeutic developments in Friedreich ataxia
@nl
P2860
P3181
P356
P1476
Therapeutic developments in Friedreich ataxia
@en
P2093
R. B. Wilson
P2860
P304
P3181
P356
10.1177/0883073812449691
P407
P577
2012-09-01T00:00:00Z